Phase II study of melphalan, prednisone and lenalidomide combination for newly diagnosed multiple myeloma patients who are not candidates for stem cell transplantation [abstract] - Roy, V; Stewart, A; Bergsagel, P (Blood, 2008)
; 112 Abstract 2769.